{{Rsnum
|rsid=3849150
|Gene=WDFY4
|Chromosome=10
|position=50109223
|Orientation=plus
|GMAF=0.1134
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 73.5 | 21.2 | 5.3
| HCB | 98.5 | 1.5 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 59.9 | 36.7 | 3.4
| ASW | 56.1 | 36.8 | 7.0
| CHB | 98.5 | 1.5 | 0.0
| CHD | 99.1 | 0.9 | 0.0
| GIH | 73.3 | 24.8 | 2.0
| LWK | 82.7 | 14.5 | 2.7
| MEX | 75.4 | 24.6 | 0.0
| MKK | 82.6 | 16.1 | 1.3
| TSI | 73.3 | 21.8 | 5.0
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs3849150
|PubMedID=17903303
|Condition=Other subclinical atherosclerosis traits
|Gene=LRRC18
|Risk Allele=
|pValue=2.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs3849150
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:17903303; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study (Initial Sample Size: 673-984 individuals, depending on measure (Framingham; Replication Sample Size: NR). This variant is associated with Other subclinical atherosclerosis traits.
|Drugs=
|Drug Classes=
|Diseases=Arteriosclerosis; Cardiovascular Diseases
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356504
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs3849150
|overall_frequency_n=19
|overall_frequency_d=128
|overall_frequency=0.148438
|n_genomes=13
|n_genomes_annotated=0
|n_haplomes=16
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}